✦ LIBER ✦

Survivin expression in “low-risk” and “high-risk” myelodysplastic syndromes

✍ Scribed by Umberto Gianelli; Nicola Stefano Fracchiolla; Agostino Cortelezzi; Caterina Pellegrini; Federica Savi; Alessia Moro; Maria Grazia Grimoldi; Giorgio Lambertenghi Deliliers; Guido Coggi; Silvano Bosari

Book ID: 105988863
Publisher: Springer
Year: 2006
Tongue: English
Weight: 166 KB
Volume: 86
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-006-0215-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-Risk Myelodysplastic Syndromes: Che

High-Risk Myelodysplastic Syndromes: Chemotherapy, Transplantation, and Beyond

✍ Usama Gergis; Usama Wissa 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 153 KB

Increased AF1q gene expression in high-r

Increased AF1q gene expression in high-risk myelodysplastic syndrome

✍ William Tse; H. Joachim Deeg; Derek Stirewalt; Frederick R. Appelbaum; Jerald Ra 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Reduced expression of FLIPSHORT in bone

Reduced expression of FLIPSHORT in bone marrow of low risk myelodysplastic syndrome

✍ Paula de Melo Campos; Fabíola Traina; Adriana da Silva Santos Duarte; Irene Lora 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Apoptosis is dysregulated in patients with myelodysplastic syndrome (MDS) and acute myelogenous leukaemia (AML). FLIP (FLICE (FAS-associated death-domain-like IL-1 beta-converting enzyme)-inhibitory protein) has been described as an anti-apoptotic protein. Here, we characterize the expression level

Identification of a risk dependent micro

Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes

✍ Lubomir Sokol; Gisela Caceres; Stefano Volinia; Hans Alder; Gerard J. Nuovo; Cha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB

Effectiveness and tolerance of low to ve

Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes

✍ J. Tamburini; C. Elie; S. Park; O. Beyne-Rauzy; M. Gardembas; C. Berthou; B. Mah 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Prognostic impact of severe thrombocytop

Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome

✍ Jose Ramon Gonzalez-Porras; Iris Cordoba; Esperanza Such; Benet Nomdedeu; Teresa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 1 views

## Abstract ## BACKGROUND: Thrombocytopenia is very common in myelodysplastic syndrome (MDS); however, its clinical impact in low‐risk patients remains controversial. ## METHODS: The authors analyzed the incidence and prognostic significance of thrombocytopenia at diagnosis in 2565 de novo MDS p